BUST FENTANYL Act

Summary

Changes U.S. drug‑policy reporting and expands sanction authorities to target international fentanyl and synthetic‑opioid trafficking. It moves an annual report deadline, requires new unclassified reports (with classified annexes) and briefings on PRC‑linked trafficking and DEA presence in Chinese cities, prioritizes identification and designation of PRC persons and entities for sanctions, broadens the kinds of conduct that can trigger designations, allows sanctioning of foreign government subunits and senior officials that materially support trafficking, and adds an annual requirement to identify major methamphetamine source countries and their anti‑diversion efforts.

• Moves an existing international narcotics report deadline from March 1 to June 1 and trims statutory chemical‑listing text.
• Requires an unclassified State/DOJ report (with classified annex) and a classified briefing on PRC‑involved fentanyl/synthetic opioid trafficking within 180 days.
• Directs the President to prioritize identifying PRC persons/entities for sanctions under the Fentanyl Sanctions Act until PRC is no longer primary source.
• Expands statutory grounds for designation to include knowingly facilitating trafficking, handling proceeds, providing significant support, and ownership/control relationships.
• Permits sanctions on foreign government subdivisions, agencies, instrumentalities, and senior officials that knowingly support or engage in conduct materially contributing to opioid trafficking.
• Adds an annual reporting requirement to identify major methamphetamine source countries and assess their anti‑diversion and anti‑trafficking efforts.
• Requires new interagency coordination and increases investigative/targeting focus on supplier/manufacturer/shipper networks tied to synthetic opioids.
• Implements definitional and deadline changes that extend sanction authorities and create a presidential certification pathway to change PRC prioritization.